Increased frequency of intracellular interleukin (IL)-13 and IL-10, but not IL-4, expressing CD4+ and CD8+ peripheral T cells of patients with atopic dermatitis

British Journal of Dermatology

Volumn 147, Issue 6, 2002, Pages 1135-1141

  Aleksza, M ^a   Irinyi, B ^a   Lukacs A ^a   Antal Szalmas P ^a   Hunyadi, J ^a   Szegedi, Andrea ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Atopic dermatitis; CD4+ cells; CD8+ cells; Flow cytometry; Interleukin 13; Interleukin 4

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN DERIVATIVE;

ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ARTICLE; ATOPIC DERMATITIS; CELL SURFACE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HELPER CELL; HUMAN; IMMUNOREGULATION; INTERFERON PRODUCTION; LYMPHOCYTE SUBPOPULATION; MALE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE ACTIVATION; BLOOD; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION;

ADOLESCENT; ADULT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHILD; DERMATITIS, ATOPIC; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN-10; INTERLEUKIN-13; INTERLEUKIN-4; INTERLEUKINS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; MALE;

EID: 0036886908     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2002.05013.x     Document Type: Article

References (44)

1. Singh VK, Mehrotra S, Agarwal SS. The paradigm of Th1 and Th2 cytokines: its relevance to autoimmunity and allergy. Immunol Res 1999; 20: 147-61.
2. Leung DYM. Pathogenesis of atopic dermatitis. J Allergy Clin Immunol 1999; 104: 99-108.
3. Grewe M, Bruijnzeel-Koomen CAFM, Schöpf E et al. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today 1998; 19: 359-61.
4. Leung DYM. Atopic dermatitis: new insights and opportunities for therapeutic intervention. J Allergy Clin Immunol 2000; 105: 860-76.
5. Hamid O, Boguniewicz M, Leung DYM. Differential in situ cytokine gene expression in acute vs chronic atopic dermatitis. J Clin Invest 1994; 94: 870-6.
6. Hamid O, Naseer T, Minshall EM et al. In vivo expression of IL-12 and IL-13 in atopic dermatitis. J Allergy Clin Immunol 1996; 98: 225-31.
7. Sager N, Feldmann A, Schilling G et al. House dust mite-specific T cells in the skin of subjects with atopic dermatitis: frequency and lymphokine profile in the allergen patch test. J Allergy Clin Immunol 1992; 4: 801-10.
8. Werfel T, Morita A, Grewe M et al. Allergen specificity of skin-infiltrating T cells is not restricted to a type-2 cytokine pattern in chronic skin lesions of atopic dermatitis. J Invest Dermatol 1996; 107: 871-6.
9. Renz H, Jujo K, Bradley KL et al: Enhanced IL-4 production and IL-4 receptor expression in atopic dermatitis and their modulation by interferon-gamma. J Invest Dermatol 1992; 99: 403-7.
10. Jujo K, Renz H, Abe J et al. Decreased interferon gamma and increased interleukin-4 production in atopic dermatitis promotes IgE synthesis. J Allergy Clin Immunol 1992; 90: 323-30.
11. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl 1980; 92: 44-7.
12. European Task Force on Atopic Dermatitis. Severity Scoring of Atopic Dermatitis. The SCORAD Index. Dermatology 1993; 198: 23-31.
13. Prussin C, Metcalfe DD. Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies. J Immunol Methods 1995; 188: 117-28.
14. Uehara M, Izukura R, Sawai T. Blood eosinophilia in atopic dermatitis. Clin Exp Dermatol 1990; 15: 264-6.
15. Walker C, Kagi MK, Ingold P et al. Atopic dermatitis: correlation of peripheral blood T cell activation, eosinophilia and serum factors with clinical severity. Clin Exp Allergy 1993; 23: 145-53.
16. Miadonna A, Tedeschi A, Leggieri E et al. Characterization of T cell subsets in patients with atopic dermatitis using OKT monoclonal antibodies. Ann Allergy 1985; 54: 321-4.
17. Braathen LR. T-cell subsets in patients with mild and severe atopic dermatitis. Acta Derm Venereol Suppl 1985; 114: 133-6.
18. Tang M, Kemp A, Varigos G. IL-4 and interferon-gamma production in children with atopic disease. Clin Exp Immunol 1993; 92: 120-4.
19. Tang MLK, Kemp AS, Thorburn J et al. Reduced interferon-γ secretion in neonates and subsequent atopy. Lancet 1994; 344: 983-5.
20. Nakazawa M, Sugi N, Kawaguchi H et al. Predominance of type 2 cytokine-producing CD4+ and CD8+ cells in patients with atopic dermatitis. J Allergy Clin Immunol 1997; 99: 673-82.
21. Katagiri K, Itami S, Hatano Y et al. Increased levels of IL-13 mRNA, but not IL-4 mRNA, are found in vivo in peripheral blood mononuclear cells (PBMC) of patients with atopic dermatitis (AD). Clin Exp Immunol 1997; 108: 189-94.
22. Takamatsu Y, Hasegawa M, Sato S et al. IL-13 production by peripheral blood mononuclear cells from patients with atopic dermatitis. Dermatology 1998; 196: 377-81.
23. + T cells respond to superantigen and contribute to eosinophilia and IgE production in atopic dermatitis. J Immunol 1999; 163: 466-75.
24. + memory T ceils are activated in atopic dermatitis and regulate IgE by an IL13-dominated cytokine pattern. J Immunol 1997; 159: 4611-19.
25. Teraki Y, Hotta T, Shiohara T. Increased circulating skin-homing cutaneous lymphocyte-associated antigen (CLA)+ type 2 cytokine-producing cells, and decreased CLA+ type 1 cytokine-producing cells in atopic dermatitis. Br J Dermatol 2000; 143: 373-8.
26. Sato A, Tsuji K, Yamamura M et al. Increased type 2 cytokine expression by both CD4+ CD45RO+ T cells and CD8+ CD45RO+ T cells in blood circulation is associated with high serum IgE but not with atopic dermatitis. J Invest Dermatol 1998; 111 (6): 1079-84.
27. Lee HJ, Lee HP, Ha SJ et al. Spontaneous expression of mRNA for IL-10, GM-CSF, TGF-beta, and IL-6 in peripheral blood mononuclear cells from atopic dermatitis. Ann Allergy Asthma Immunol 2000; 84(5): 553-8.
28. Ohmen ID, Hanifin JM, Nickoloff BJ et al. Overexpression of IL-10 in atopic dermatitis. Contrasting cytokine patterns with delayed-type hypersensitivity reactions. J Immunol 1995; 154: 1956-63.
29. Minty A, Chalon P, Derocq JM et al. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 1993; 362: 248-50.
30. McKenzie ANJ, Culpepper JA, Malefyt DW et al. Interleukin-13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. Proc Natl Acad Sci USA 1993; 90: 3735-9.
31. Burd PR, Thompson WC, Max EE et al. Activated mast cells produce interleukin 13. J Exp Med 1995; 181: 1373-80.
32. Punnonen J, Aversa G, Cocks BG. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci USA 1993; 90: 3730-4.
33. De Vries JE, Zurawski G. Immunoregulatory properties of IL-13: its potential role in atopic disease. Int Arch Allergy Immunol 1995; 106: 175-9.
34. de Waal Malefyt R, Abrams JS, Zurowski SM et al. Differential regulation of IL-13 and IL-4 production by human CD8+ and CD4+ Th0, Th1 and Th2 T cell clones and EBV-transformed B cells. Int Immunol 1995; 7: 1405-16.
35. Del Prete G, De Carli M, Almerigogna F et al. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 1993; 150: 353-60.
36. Wakkach A, Cottrez F, Groux H. Can interleukin-10 be used as a true immunoregulatory cytokine? Eur Cytokine Netw 2000; 11(2): 153-60.
37. Lester MR. Hofer MF, Gately M et al. Down-regulating effects of IL-4 and IL-10 on the IFN-gamma response in atopic dermatitis. J Immunol 1995; 154(11): 6174-81.
38. Rousset F, Garcia E, Defrance T. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA 1992; 89: 1890-3.
39. Levings MK, Roncarolo MG. T regulatory 1 cells: a novel subset of CD4 T cells with immunoregulatory properties. J Aller Clin Immunol 2000; 106(1 Part 2): S109-12.
40. Jung T, Lack G, Schauer U et al. Decreased frequency of interferon-γ and interleukin-2-producing cells in patients with atopic diseases measured at the single cell level. J Allergy Clin Immunol 1995; 96: 515-27.
41. Lewis DB, Yu CC, Meyer J. Cellular and molecular mechanisms for reduced interleukin 4 and interferon-γ production by neonatal T cells. J Clin Invest 1991; 87: 194-202.
42. Maggi E, Gindizi MG, Biagiotti R et al. Th2-like CD8+ T cells showing B cells helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection. J Exp Med 1994; 180: 489-95.
43. + T cells secreting Th1 or Th2 cytokines. Immunity 1995; 2: 271-9.
44. Kägi MK, Wüthrict B, Montano E et al. Differential cytokine profiles in peripheral blood lymphocyte supernatants and skin biopsies from patients with different forms of atopic dermatitis, psoriasis and normal individuals. Int Arch Allergy Immunol 1994; 9: 332-40.